Categories: News

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the third quarter 2024 before market open on Tuesday, October 29, 2024.

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

Staff

Recent Posts

PDS Health Recognized with Four Viddy Awards for Excellence in Video Storytelling

Award-winning videos highlight PDS Health's integrated care platform and celebrate regional teamwork through creative storytelling…

8 minutes ago

Aesthetic Partners Welcomes Healthcare Leader Mark Censoprano to Its Board Leadership Team

MIAMI, July 28, 2025 /PRNewswire/ -- Aesthetic Partners, a leading medical aesthetics and plastic surgery…

6 hours ago

IMV Announces Initial Winners of 2025 ServiceTrak™ Clinical Laboratory Awards, Honored at ADLM Annual Conference

ARLINGTON, Va., July 28, 2025 /PRNewswire/ -- IMV, part of the Science and Medicine Group…

6 hours ago

Trella Health Releases 2025 Post-Acute Care Industry Trend Report Highlighting Continued Medicare Advantage Growth and Shifts in Care Utilization

New annual report reveals national and state-level trends across home health, hospice, and skilled nursing.…

6 hours ago

$10 Million Philanthropic Donation Launches Research Effort into Root Causes of Stuttering

COSTA MESA, Calif., July 28, 2025 /PRNewswire/ -- The newly founded Stuttering Treatment and Research Society…

6 hours ago